Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization.
暂无分享,去创建一个
[1] L. Weinehall. The emerging epidemic of cardiovascular disease History and background of the Northern Sweden initiative on cardiovascular disease , 2003, Scandinavian journal of public health. Supplement.
[2] R. Bonita,et al. Global health status: two steps forward, one step back , 2000, The Lancet.
[3] A. Siani,et al. Increasing evidence for the role of salt and salt-sensitivity in hypertension. , 2000, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[4] K. Reddy,et al. The World Heart Federation's white book: impending global pandemic of cardiovascular diseases: challenges and opportunities for the prevention and control of cardiovascular diseases in developing countries and economies in transition. , 2000, The Canadian journal of cardiology.
[5] Sarah Parish,et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls , 1999, The Lancet.
[6] Sonia S Anand. Using ethnicity as a classification variable in health research: perpetuating the myth of biological determinism, serving socio-political agendas, or making valuable contributions to medical sciences? , 1999, Ethnicity & health.
[7] S. Yusuf,et al. Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[8] S. Yusuf,et al. Emerging epidemic of cardiovascular disease in developing countries. , 1999, Circulation.
[9] P. Whelton,et al. Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. , 1999, The New England journal of medicine.
[10] S. Yusuf,et al. Relationship of glucose and insulin levels to the risk of myocardial infarction: a case-control study. , 1999, Journal of the American College of Cardiology.
[11] S. Yusuf,et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. , 1999, Diabetes care.
[12] B. Popkin. The nutrition transition and its health implications in lower-income countries , 1998, Public Health Nutrition.
[13] M. Mckee,et al. Huge variation in Russian mortality rates 1984–94: artefact, alcohol, or what? , 1997, The Lancet.
[14] Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.
[15] R Doll,et al. Mortality in relation to smoking: 40 years' observations on male British doctors , 1994, BMJ.
[16] D. Barker. Mothers, Babies and Disease in Later Life , 1994 .
[17] J. Stengård,et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.
[18] D. Jamison,et al. Disease Control Priorities in Developing Countries , 1993 .
[19] J E Keil,et al. Socioeconomic factors and cardiovascular disease: a review of the literature. , 1993, Circulation.
[20] M. Marmot,et al. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians , 1991, The Lancet.
[21] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.
[22] J. Neaton,et al. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.
[23] R F Heller,et al. How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. , 1984, British medical journal.
[24] S. Syme,et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. , 1974, Journal of chronic diseases.
[25] A. Omran. The epidemiologic transition. A theory of the epidemiology of population change. , 1971, The Milbank Memorial Fund quarterly.
[26] THE WORLD HEALTH ORGANIZATION , 1954 .
[27] S. Yusuf,et al. Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE). , 2000, Indian heart journal.
[28] J. Murray,et al. The Global Burden of Disease , 1996 .
[29] L. Gallo. Cardiovascular Disease , 1995, GWUMC Department of Biochemistry Annual Spring Symposia.
[30] U. Goldbourt,et al. Genetic factors in coronary heart disease , 1994, Developments in Cardiovascular Medicine.
[31] R. Lozano,et al. The epidemiologic transition and health priorities. , 1993 .
[32] M. Kogevinas,et al. Socioeconomic status and disease. , 1991, WHO regional publications. European series.
[33] D. Galton,et al. Lipids and cardiovascular disease , 1990 .
[34] M. Kornitzer,et al. The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration , 1988 .
[35] Principal Investigators,et al. The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): a major international collabaration , 1988 .
[36] G. Burch. [Cardiovascular diseases]. , 1956, Revista medica cubana.